Published in Am Rev Respir Dis on September 01, 1973
Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax (1978) 2.05
Comparison of two methods of administering bronchodilator aerosol to asthmatic patients. Br Med J (1975) 1.74
Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man. Br J Clin Pharmacol (1975) 1.16
Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG). J Aerosol Med Pulm Drug Deliv (2011) 0.99
Comparison of salbutamol given by intermittent positive-pressure breathing and pressure-packed aerosol in chronic asthma. Thorax (1982) 0.83
Letter: Exfoliative dermatitis during treatment with pheneturide. Br Med J (1975) 0.75
The effect of different nebulizers with and without intermittent positive pressure breathing on the absorption and metabolism of salbutamol. Br J Clin Pharmacol (1974) 0.75
Management of severe acute asthma. Br Med J (1978) 0.75
The "five minute" consultation: effect of time constraint on clinical content and patient satisfaction. Br Med J (Clin Res Ed) (1986) 15.01
The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther (1973) 4.56
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02
Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) (1985) 2.67
Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax (1973) 2.64
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
A comparison of three different techniques for giving nebulized albuterol to asthmatic patients. Am Rev Respir Dis (1974) 2.57
Bronchodilator drugs. Am Rev Respir Dis (1979) 2.24
SElectivity of broncholidlator action of salbutamol in asthmatic patients. Br J Dis Chest (1971) 2.15
Influence of the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant agonists. Br J Pharmacol (1986) 2.07
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Are medication record cards useful? Med J Aust (1995) 2.04
The involvement of the frontal lobes in cognitive estimation. Cortex (1978) 2.02
Preparation of Scarlet Fever Toxin. Am J Public Health Nations Health (1939) 2.02
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
The fate of ( 14 C)disodium cromoglycate in man. J Pharm Pharmacol (1972) 1.97
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest (1978) 1.89
The metabolism of salbutamol in man. Xenobiotica (1973) 1.88
Patterns of antibiotic-resistant Streptococcus pneumoniae in children in a day-care setting. J Fam Pract (1998) 1.80
In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br J Clin Pharmacol (1986) 1.73
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Intracerebral propagation of interictal activity in partial epilepsy: implications for source localisation. J Neurol Neurosurg Psychiatry (1994) 1.66
Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66
Clinical evaluation of clobetasone butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure. Br J Ophthalmol (1980) 1.61
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
Increasing hospital employee participation in an influenza vaccine program. Am J Infect Control (1998) 1.52
Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria. Biochem J (1970) 1.51
Influence of thyroid dysfunction on drug pharmacokinetics. Clin Pharmacokinet (1981) 1.49
Beta-adrenergic blocking drugs. Br Med J (1971) 1.49
Metabolic and ventilatory changes in asthmatic patients during and after exercise. Thorax (1972) 1.48
Pharmacokinetics of inhaled salbutamol in asthmatic patients. Br J Pharmacol (1971) 1.47
Species differences in the metabolism of sulphadimethoxine. Biochem J (1968) 1.47
Hereditary occurrence of cystic disease of the renal medulla. N Engl J Med (1966) 1.46
Plasma prednisolone levels in man following administration in plain and enteric-coated forms. Br J Clin Pharmacol (1977) 1.46
Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br J Clin Pharmacol (1988) 1.45
Cefuroxime plasma and CSF levels in children with meningitis. Arch Dis Child (1979) 1.44
An evaluation of statewide strategies to reduce antibiotic overuse. Fam Med (2000) 1.43
Potential interaction between isoniazid and selective serotonin-reuptake inhibitors. Am J Health Syst Pharm (1995) 1.43
Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Br Med J (1976) 1.42
Effect of raised intraocular pressure on the retinal and choroidal circulation. Invest Ophthalmol (1968) 1.38
Immunocytochemical localization of the major surfactant apoproteins in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem (1986) 1.38
Metabolism of isoprenaline in dog and man. Br J Pharmacol (1972) 1.38
Peripheral thrombolysis for acute-onset claudication. Thrombolysis Study Group. Br J Surg (1999) 1.38
Pharmacological responses of human and porcine lung parenchyma, bronchus and pulmonary artery. Br J Pharmacol (1982) 1.33
Ibuprofen. A review. Practitioner (1971) 1.33
Species differences in the metabolism and excretion of sulphasomidine and sulphamethomidine. Biochem J (1969) 1.31
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer (1995) 1.28
Effect of intravenous injection of salbutamol in asthma. Br J Clin Pharmacol (1975) 1.26
Quantitative microfocal radiography accurately detects joint changes in rheumatoid arthritis. Ann Rheum Dis (1986) 1.23
Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing (1994) 1.22
Rapid onset of proliferative retinopathy in young insulin-independent diabetics. Br Med J (1976) 1.19
Blood-levels of fluorinated hydrocarbons in asthmatic patients after inhalation of pressurised aerosols. Lancet (1971) 1.18
Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol (1980) 1.16
Effect of steroids on beta-adrenoceptor-mediated relaxation of pig bronchus. Br J Pharmacol (1983) 1.15
Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet (1998) 1.14
Measurement of plasma prednisolone in man. Br J Clin Pharmacol (1975) 1.13
The fate of (3H)salbutamol in man. Biochem J (1971) 1.13
Co-axial bioassay of a smooth muscle relaxant factor released from guinea-pig tracheal epithelium. Br J Pharmacol (1989) 1.13
Adverse reactions to beta 2-agonist bronchodilators. Med Toxicol (1986) 1.12
The effect on plasma corticosteroid levels of the short term topical application of clobetasol propionate. Br J Dermatol (1974) 1.11
Medication-related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev (1995) 1.11
Amiloride hydrochloride in hypertensive patients. Br Med J (1968) 1.09
Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury. Gut (2005) 1.09
Structure and species as factors affecting the metabolism of some methoxy-6-sulphanilamidopyrimidines. Biochem J (1969) 1.08
Identification of rat alveolar type II epithelial cells with a tannic acid and polychrome stain. Am Rev Respir Dis (1985) 1.08
Effect of restrictions on prescribing patterns for dextropropoxyphene. Br Med J (1980) 1.06
Levofloxacin failure in a patient with pneumococcal pneumonia. Ann Pharmacother (2001) 1.04
Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure. Br J Ophthalmol (1981) 1.04
Classification of beta-adrenoceptors in human isolated bronchus. Br J Pharmacol (1984) 1.03
Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1985) 1.03
Tularemia and rhabdomyolysis. JAMA (1985) 1.02
Correlations between pharmacological responses and structure of human lung parenchyma strips. Br J Pharmacol (1983) 1.01
Autoradiographic localization of beta-adrenoceptors in asthmatic human lung. Am Rev Respir Dis (1989) 1.01
Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J Infect Dis (1989) 1.00
Uptake of alternative medicine. Lancet (1996) 0.99
Arterial fluorescein studies in diabetic retinopathy. Diabetes (1967) 0.98
Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain. N Engl J Med (1975) 0.98
Incidence and size of erosions in the wrist and hand of rheumatoid patients: a quantitative microfocal radiographic study. Ann Rheum Dis (1987) 0.98
Pregnancy attributable to interaction between tetracycline and oral contraceptives. Br Med J (1980) 0.97
Human pharmacology: comparison of intravenous isoprenaline and salbutamol in asthmatic patients. Postgrad Med J (1971) 0.97
An in vitro study of various drugs on central and peripheral airways of the rat: a comparison with human airways. Br J Pharmacol (1980) 0.96